Data month 2026-08
According to AlphaMoat, in 2026-08 ImpriMed (imprimedicine.com) received 49,189 monthly visits (-2.1% MoM) — ranked #5,199 of 17,407 AI websites with traffic data, and #629 of 3,173 in Industry Services; its largest market is United States (46.0% of visits).
Monthly Visits · 2026-08
49.2K-2.1%
Overall Rank (17,407)
#5,199
Industry Services Rank (3,173)
#629
Top Market
United States46.0%
What is ImpriMed
Product Overview
ImpriMed is an AI precision-medicine company for veterinary oncology that helps doctors match the most suitable drugs for blood cancers in dogs and cats.
Key Features4 items
- 01Combines ex-vivo live-cell analysis
- 02AI predictive models
- 03Patient-specific drug-response prediction
- 04Extends to CRO analysis for human oncology
Business Model
It provides precision-medicine analysis and CRO services to veterinary oncology clinics, hospitals, and human-oncology pharmaceutical companies.
12-Month Traffic Trend
Hover for monthly values
Latest 49.2KMoM-2.1%
2026-06
58.6K
—
2026-07
50.3K
-14.3%
2026-08
49.2K
-2.1%
Visits by Country · Top 5
2026-08 · Share of total visits
United States
22,64546.0%
South Korea
6,73913.7%
Canada
3,1986.5%
Australia
3,1966.5%
UK
2,8285.7%
Popular in Industry Services
Click for details, or "+ Compare" to compare with ImpriMed
Data month: 2026-08 · Visit figures are third-party traffic estimates aggregated monthly — best for scale and trends. Multiple domains of the same product are merged. See methodology.